Feng Chi Biotech Corp. (TPEX:6744)
11.50
0.00 (0.00%)
Nov 19, 2026, 12:45 PM CST
Feng Chi Biotech Market Cap
Feng Chi Biotech has a market cap or net worth of 177.1 million as of November 20, 2026. It is the 44,246th most valuable company in the world and the 2,357th biggest in Taiwan. Its market cap has decreased by 38.50% in one year.
Market Cap
177.10M
Enterprise Value
9.79M
Revenue
156.99M
Global Rank
Country Rank
#2,357 Taiwan
PE Ratio
17.88
ChartMarket Cap Chart
Since September 25, 2019, Feng Chi Biotech's market cap has decreased from 742.28M to 177.10M, a decrease of -76.14%. That is a compound annual growth rate of -18.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2026 | 177.10M | -35.39% |
| Dec 31, 2025 | 274.12M | -10.10% |
| Dec 30, 2024 | 304.92M | -10.81% |
| Dec 29, 2023 | 341.88M | 11.00% |
| Dec 29, 2022 | 308.00M | -19.19% |
| Dec 28, 2021 | 381.15M | -16.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GeneReach Biotechnology | 756.21M |
| NatureWise Biotech & Medicals | 690.51M |
| BioLASCO Taiwan | 681.28M |
| Neith | 620.65M |
| Taiwan Advance Bio-Pharmaceutical | 584.10M |
| SynCore Biotechnology Co.,Ltd | 566.16M |
| Vectorite Biomedical | 466.16M |
| LAUNXP Biomedical | 451.12M |